Search Results 1261-1270 of 18508 for Prednisone

1. A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   * Received systemic corticosteroids equivalent to prednisone >10 mg/day or equivalent within 2 weeks of screening period. * Use of any of the following ...

2. Abaloparatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Abaloparatide is used to treat osteoporosis, and reduces the risk of having bone and spine fractures, in postmenopausal women with osteoporosis. It also ...

3. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

   Treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and ...

4. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other ...

5. Allergy shots - Mayo Clinic

   Each allergy shot contains a tiny amount of the substance or substances that trigger allergic reactions. These substances are called allergens. Allergy shots ...

6. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer - Mayo Clinic

   NOTE: Patients who have received acute, low-dose systemic steroids (≤ 10 mg/day oral prednisone or equivalent) prior to registration or a one-time pulse ...

7. Publications - Matt R. Starr, M.D. - Mayo Clinic

   Starr MR, Maguire LJ, Salomão DR. Bilateral Corneal Deposits 1 Week After Starting Oral Prednisone Therapy. JAMA Ophthalmol. 2018 May 01; 136(5):591-592. View ...

8. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (I a dose exceeding 10 mg daily of prednisone equivalent). Note ...

9. Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty - Mayo Clinic

   Patients on systemic glucocorticoid therapy (prednisone >10 mg/day or equivalent). 9. Patients who are immunodeficient (e.g., splenectomy, sickle cell ...

10. A Study to Evaluate Lenalidomide and Dexamethasone, with or without Daratumumab, in Treating High-Risk Smoldering Myeloma Patients - Mayo Clinic

    ... prednisone 10 mg per day. Prior or concurrent topical or localized glucocorticosteroid therapy to treat non-malignant comorbid disorders is permitted ...